Coronavirus disease 2019(6) COVID-19(5) severe acute respiratory syndrome coronavirus 2(4) pandemic(3) Thoracic surgery.(3) coronavirus(3) mammalian(2) Vaccine(2) significantly(2) prospective cohort study(2) Immunoglobulin(2) of BNT162b2(2) General population(2) Protective measures(2) booster(2) Serum level(2) positive(2) significantly increased(2) immunogenicity(2) baseline(2) BNT162b2(2) Heart transplantation(2) Critical care(2) inhibitor(2) dose(2) titre(2) non-responder(2) BNT162b2 vaccine(2) proportion(2) inhibitors(2)